Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Heartware Ltd (ASX:HTW)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Heartware Ltd.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1389072.
Total stock buying since 2014: $7,746,531.
Total stock sales since 2014: $29,404,346.
Total stock option exercises since 2014: $176,876.
Table 3. Detailed insider trading at Heartware Ltd (ASX:HTW)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2016-07-22 | Strong Mark (Senior VP, R&D and Quality) | Sale | 1,875 | 57.71 | 108,206 |
2016-07-21 | Strong Mark (Senior VP, R&D and Quality) | Option Ex | 2,500 | .00 | 0 |
2016-07-11 | Mcaree Peter F (SVP, CFO and Treasurer) | Sale | 3,125 | 57.68 | 180,250 |
2016-07-09 | Mcaree Peter F (SVP, CFO and Treasurer) | Option Ex | 6,250 | .00 | 0 |
2016-07-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 57.77 | 57,770 |
2016-06-01 | Harrison Seth Loring (Director) | Option Ex | 1,000 | .00 | 0 |
2016-06-01 | Wade Denis Newell (Director) | Option Ex | 1,000 | .00 | 0 |
2016-06-01 | Stockman Robert Bernard (Director) | Option Ex | 1,000 | .00 | 0 |
2016-06-01 | Feldmann Cynthia L (Director) | Option Ex | 1,000 | .00 | 0 |
2016-06-01 | Barberich Timothy J (Director) | Option Ex | 1,000 | .00 | 0 |
2016-06-01 | Larkin C Raymond Jr (Director) | Option Ex | 1,000 | .00 | 0 |
2016-05-01 | Harrison Seth Loring (Director) | Option Ex | 500 | .00 | 0 |
2016-05-01 | Wade Denis Newell (Director) | Option Ex | 500 | .00 | 0 |
2016-05-01 | Stockman Robert Bernard (Director) | Option Ex | 500 | .00 | 0 |
2016-05-01 | Thomas Robert Bain (Director) | Option Ex | 500 | .00 | 0 |
2016-05-01 | Feldmann Cynthia L (Director) | Option Ex | 750 | .00 | 0 |
2016-05-01 | Barberich Timothy J (Director) | Option Ex | 500 | .00 | 0 |
2016-05-01 | Larkin C Raymond Jr (Director) | Option Ex | 500 | .00 | 0 |
2016-02-29 | Oesterle Stephen N (Director) | Buy | 1,000 | 32.17 | 32,170 |
2016-01-04 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 48.51 | 48,510 |
2015-12-22 | Yocher Robert E (SVP Regulatory Affairs) | Sale | 332 | 46.98 | 15,595 |
2015-12-22 | Knopf Lawrence J (General Counsel) | Sale | 721 | 46.91 | 33,818 |
2015-12-22 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,202 | 46.92 | 56,397 |
2015-12-22 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,221 | 46.92 | 57,289 |
2015-12-22 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 4,324 | 46.88 | 202,730 |
2015-12-21 | Yocher Robert E (SVP Regulatory Affairs) | Option Ex | 1,000 | .00 | 0 |
2015-12-21 | Knopf Lawrence J (General Counsel) | Option Ex | 1,500 | .00 | 0 |
2015-12-21 | Schuermann James (SVP, Sales & Marketing) | Sale | 553 | 46.54 | 25,736 |
2015-12-21 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 2,500 | .00 | 0 |
2015-12-21 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 4,375 | .00 | 0 |
2015-12-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 9,000 | .00 | 0 |
2015-12-20 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,666 | .00 | 0 |
2015-10-01 | Strong Mark (Senior VP, R&D and Quality) | Sale | 2,625 | 52.68 | 138,285 |
2015-10-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 53.12 | 53,120 |
2015-09-30 | Strong Mark (Senior VP, R&D and Quality) | Option Ex | 3,500 | .00 | 0 |
2015-08-26 | Leadley Katrin (Chief Medical Officer) | Sale | 3,750 | 80.31 | 301,162 |
2015-08-25 | Leadley Katrin (Chief Medical Officer) | Option Ex | 3,750 | .00 | 0 |
2015-08-03 | Gross Phillip | Sale | 35,000 | 90.33 | 3,161,410 |
2015-07-31 | Gross Phillip | Sale | 75,000 | 92.00 | 6,900,000 |
2015-07-22 | Strong Mark (Senior VP, R&D and Quality) | Sale | 1,875 | 88.06 | 165,112 |
2015-07-21 | Strong Mark (Senior VP, R&D and Quality) | Option Ex | 2,500 | .00 | 0 |
2015-07-10 | Mcaree Peter F (SVP, CFO and Treasurer) | Sale | 3,125 | 73.66 | 230,171 |
2015-07-09 | Mcaree Peter F (SVP, CFO and Treasurer) | Option Ex | 6,250 | .00 | 0 |
2015-07-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 72.78 | 72,780 |
2015-06-24 | Yocher Robert E (SVP Regulatory Affairs) | Sale | 829 | 77.41 | 64,172 |
2015-06-23 | Yocher Robert E (SVP Regulatory Affairs) | Option Ex | 2,500 | .00 | 0 |
2015-05-12 | Harrison Seth Loring (Director) | Option Ex | 250 | .00 | 0 |
2015-05-12 | Wade Denis Newell (Director) | Option Ex | 250 | .00 | 0 |
2015-05-12 | Stockman Robert Bernard (Director) | Option Ex | 250 | .00 | 0 |
2015-05-12 | Thomas Robert Bain (Director) | Option Ex | 250 | .00 | 0 |
2015-05-12 | Barberich Timothy J (Director) | Option Ex | 250 | .00 | 0 |
2015-05-12 | Larkin C Raymond Jr (Director) | Option Ex | 250 | .00 | 0 |
2015-05-01 | Harrison Seth Loring (Director) | Option Ex | 1,500 | .00 | 0 |
2015-05-01 | Wade Denis Newell (Director) | Option Ex | 1,500 | .00 | 0 |
2015-05-01 | Stockman Robert Bernard (Director) | Option Ex | 1,500 | .00 | 0 |
2015-05-01 | Thomas Robert Bain (Director) | Option Ex | 1,500 | .00 | 0 |
2015-05-01 | Feldmann Cynthia L (Director) | Option Ex | 1,750 | .00 | 0 |
2015-05-01 | Barberich Timothy J (Director) | Option Ex | 1,500 | .00 | 0 |
2015-05-01 | Larkin C Raymond Jr (Director) | Option Ex | 1,500 | .00 | 0 |
2015-04-21 | Gross Phillip | Sale | 21,947 | 80.50 | 1,766,733 |
2015-04-20 | Gross Phillip | Sale | 88,534 | 80.50 | 7,126,809 |
2015-04-17 | Gross Phillip | Sale | 62,786 | 81.41 | 5,111,471 |
2015-04-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 86.58 | 86,575 |
2015-03-30 | Knopf Lawrence J (General Counsel) | Sale | 1,741 | 89.18 | 155,262 |
2015-03-28 | Knopf Lawrence J (General Counsel) | Option Ex | 5,250 | .00 | 0 |
2015-02-25 | Strong Mark (Senior VP, R&D and Quality) | Sale | 395 | 89.56 | 35,376 |
2015-02-25 | Yocher Robert E (SVP Regulatory Affairs) | Sale | 210 | 89.53 | 18,801 |
2015-02-25 | Knopf Lawrence J (General Counsel) | Sale | 399 | 89.52 | 35,718 |
2015-02-25 | Schuermann James (SVP, Sales & Marketing) | Sale | 574 | 89.56 | 51,407 |
2015-02-25 | Larose Jeffrey (Chief Scientific Officer) | Sale | 337 | 89.92 | 30,303 |
2015-02-25 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 1,842 | 89.58 | 165,006 |
2015-02-25 | Mcaree Peter F (SVP, CFO and Treasurer) | Sale | 464 | 89.53 | 41,541 |
2015-02-24 | Strong Mark (Senior VP, R&D and Quality) | Option Ex | 527 | .00 | 0 |
2015-02-24 | Yocher Robert E (SVP Regulatory Affairs) | Option Ex | 632 | .00 | 0 |
2015-02-24 | Knopf Lawrence J (General Counsel) | Option Ex | 1,200 | .00 | 0 |
2015-02-24 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,712 | .00 | 0 |
2015-02-24 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 1,200 | .00 | 0 |
2015-02-24 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,500 | .00 | 0 |
2015-02-24 | Mcaree Peter F (SVP, CFO and Treasurer) | Option Ex | 1,394 | .00 | 0 |
2015-02-09 | Yocher Robert E (SVP Regulatory Affairs) | Sale | 309 | 86.93 | 26,861 |
2015-02-09 | Knopf Lawrence J (General Counsel) | Sale | 510 | 86.47 | 44,099 |
2015-02-09 | Schuermann James (SVP, Sales & Marketing) | Sale | 523 | 86.45 | 45,213 |
2015-02-09 | Larose Jeffrey (Chief Scientific Officer) | Sale | 491 | 86.46 | 42,451 |
2015-02-09 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 1,698 | 87.03 | 147,785 |
2015-02-09 | Mcaree Peter F (SVP, CFO and Treasurer) | Sale | 510 | 87.05 | 44,392 |
2015-02-07 | Yocher Robert E (SVP Regulatory Affairs) | Option Ex | 800 | .00 | 0 |
2015-02-07 | Knopf Lawrence J (General Counsel) | Option Ex | 1,400 | .00 | 0 |
2015-02-07 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,600 | .00 | 0 |
2015-02-07 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 1,600 | .00 | 0 |
2015-02-07 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,000 | .00 | 0 |
2015-02-07 | Mcaree Peter F (SVP, CFO and Treasurer) | Option Ex | 1,400 | .00 | 0 |
2015-01-02 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,429 | 72.60 | 103,745 |
2015-01-02 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,429 | 21.42 | 30,609 |
2014-12-22 | Yocher Robert E (SVP Regulatory Affairs) | Sale | 333 | 73.08 | 24,335 |
2014-12-22 | Knopf Lawrence J (General Counsel) | Sale | 722 | 73.02 | 52,716 |
2014-12-22 | Schuermann James (SVP, Sales & Marketing) | Sale | 2,421 | 73.02 | 176,769 |
2014-12-22 | Larose Jeffrey (Chief Scientific Officer) | Sale | 3,072 | 72.98 | 224,194 |
2014-12-22 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 7,028 | 72.95 | 512,727 |
2014-12-21 | Yocher Robert E (SVP Regulatory Affairs) | Option Ex | 1,000 | .00 | 0 |
2014-12-21 | Knopf Lawrence J (General Counsel) | Option Ex | 1,500 | .00 | 0 |
2014-12-21 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 2,500 | .00 | 0 |
2014-12-21 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 4,375 | .00 | 0 |
2014-12-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 9,000 | .00 | 0 |
2014-12-20 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 2,917 | .00 | 0 |
2014-12-20 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 2,800 | .00 | 0 |
2014-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,612 | .00 | 0 |
2014-12-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,500 | 73.06 | 109,590 |
2014-12-01 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,500 | 22.31 | 33,465 |
2014-11-14 | Thomas Robert Bain (Director) | Sale | 500 | 80.03 | 40,015 |
2014-11-04 | Thomas Robert Bain (Director) | Sale | 1,000 | 76.99 | 76,990 |
2014-11-03 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,500 | 76.36 | 114,540 |
2014-11-03 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,500 | 23.08 | 34,620 |
2014-10-01 | Strong Mark (Senior VP, R&D and Quality) | Sale | 2,625 | 76.96 | 202,019 |
2014-09-30 | Strong Mark (Senior VP, R&D and Quality) | Option Ex | 3,500 | .00 | 0 |
2014-09-15 | Larose Jeffrey (Chief Scientific Officer) | Buy | 150 | 77.11 | 11,566 |
2014-09-15 | Gross Phillip | Buy | 65,000 | 77.19 | 5,017,350 |
2014-09-12 | Gross Phillip | Buy | 35,000 | 76.73 | 2,685,445 |
2014-09-10 | Knopf Lawrence J (General Counsel) | Sale | 465 | 78.37 | 36,442 |
2014-09-09 | Knopf Lawrence J (General Counsel) | Option Ex | 1,400 | .00 | 0 |
2014-08-19 | Larose Jeffrey (Chief Scientific Officer) | Sale | 2,179 | 81.51 | 177,610 |
2014-08-19 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 2,179 | 35.88 | 78,182 |
2014-08-18 | Thomas Robert Bain (Director) | Sale | 1,000 | 81.97 | 81,970 |
2014-07-10 | Mcaree Peter F (SVP, CFO and Treasurer) | Sale | 2,070 | 84.76 | 175,453 |
2014-07-09 | Mcaree Peter F (SVP, CFO and Treasurer) | Option Ex | 6,250 | .00 | 0 |
2014-06-24 | Yocher Robert E (SVP, Regulatory & Quality) | Sale | 822 | 89.26 | 73,371 |
2014-06-23 | Yocher Robert E (SVP, Regulatory & Quality) | Option Ex | 2,500 | .00 | 0 |
2014-05-19 | Thomas Robert Bain (Director) | Sale | 1,000 | 93.39 | 93,390 |
2014-05-14 | Thomas Robert Bain (Director) | Sale | 1,000 | 93.16 | 93,160 |
2014-05-12 | Harrison Seth Loring (Director) | Option Ex | 250 | .00 | 0 |
2014-05-12 | Wade Denis Newell (Director) | Option Ex | 250 | .00 | 0 |
2014-05-12 | Stockman Robert Bernard (Director) | Option Ex | 250 | .00 | 0 |
2014-05-12 | Thomas Robert Bain (Director) | Option Ex | 250 | .00 | 0 |
2014-05-12 | Barberich Timothy J (Director) | Option Ex | 250 | .00 | 0 |
2014-05-12 | Larkin C Raymond Jr (Director) | Option Ex | 250 | .00 | 0 |
2014-05-07 | Thomas Robert Bain (Director) | Sale | 2,000 | 93.50 | 186,994 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ASX:HTW listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Heartware Ltd (symbol ASX:HTW,
CIK number 1389072) see
the Securities and Exchange Commission (SEC) website.